St. Jude Medical named a most admired company by FORTUNE
St. Jude Medical, Inc., a global medical device company, announced that FORTUNE Magazine has named the company among the Worlds […]
Say something
St. Jude Medical, Inc., a global medical device company, announced that FORTUNE Magazine has named the company among the Worlds […]
Country-specific analysis will uate the cost effectiveness of an FFR-guided intervention strategy for patients with multivessel coronary artery disease in […]
St. Jude Medical, Inc., a global medical device company, announced the launch of the C7-XRâ„ Optical Coherence Tomography (OCT) Intravascular […]
St. Jude Medical, Inc., a global medical device company, announced the approval of the industry
New products help ensure effective therapy delivery even for patients with high defibrillation thresholds, provide additional disease management monitors for heart failure patients or patients at risk for sudden cardiac arrest and can be implanted through a smaller incision due to reduced size.
US medical device makers could face disruptions to their sales following the earthquake and tsunami that hit Japan last week, Deutsche Bank has warned.
A 62-year-old man from Shenzhen, Guangdong province has become the first patient in China to be implanted with St Jude Medical’s Eon neurostimulator, a rechargeable device used to help manage chronic pain. Despite prior back surgeries, the patient suffered from chronic back pain for more than a decade.
Global market for Cardiac Defibrillators the market is forecast to exceed USD 16 billion by 2015. The market is primarily driven by the increasing incidence of cardiovascular diseases due to aging population and the increasing availability of emergency medical services worldover for the revival of sudden cardiac death victims.